High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...

Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

Opens in a new tab or window High-dose vitamin D reduced disease activity in early MS and CIS compared with ... defined as occurrence of a relapse and/or MRI activity over 24 months of follow ...

In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain ...

Neurons collected from brain lesions in MS patients were found to accumulate new genetic mutations faster than healthy nerve ...

France: A recent randomized clinical trial, the D-Lay MS study, has demonstrated that high-dose vitamin D supplementation may ...